Background: The risk of xenozoonosis mainly by porcine endogenous retrovirus (PERV)
| INTRODUCTION
Xenotransplantation using porcine corneas has been suggested as a possible alternative to overcome an emerging shortage of human donor corneas. The physical properties of the porcine cornea are comparable to those of the human cornea, which means humans suffering from corneal blindness will see better after xenocorneal transplantation, and their use is ethically acceptable. 1 The main hurdle, huge antigenic differences between species, has been overcome in clinically applicable pig-to-non-human primate (NHP) corneal transplantation models using different immunosuppressive strategies according to the type of transplantation. Long-term survivals of decellularized porcine corneal lamellar grafts were achieved in an anterior lamellar keratoplasty (LKP) model using only steroid-based immunosuppression. 2 Even full-thickness porcine corneal grafts survived more than 6 months under an anti-CD154 antibody-based potent immunosuppressive regimen. 3 Through these promising results, clinical trials of xenocorneal transplantation are becoming a reality.
However, another obstacle to overcome is the cross-species transmission of porcine pathogens. Recently, public concerns about xenozoonosis have increased, as this happens not infrequently. The latest outbreak of Middle East respiratory syndrome in South Korea is a good example of such concerns. 4 Although no exogenous retroviruses such as human immunodeficiency virus-1 or human T-cell lymphotropic virus-1 have been found in pigs, the potential risk of infection by porcine endogenous retroviruses (PERVs), which are integrated into the genome of all pig strains, 5 has been a key safety concern as PERVs were reported to be capable of infecting human cells in vitro. 6 Unapparent infection with these viruses may cause altered gene regulation, oncogenesis, or DNA recombination in the recipient.
Xenocorneal transplantation recipients are also considered to be at risk from this xenozoonosis, even though the total number of transplanted cells is much smaller than that of other solid organs. Moreover, the longer the recipients survive with functioning xenocorneal grafts or the longer the duration of potent immunosuppression lasts, the risk of xenozoonotic infections might become greater. Therefore, to be clinically relevant, evidence on the long-term safety from PERV infection should be provided through clinically applicable xenocorneal transplantation models as well as in vitro infection experimental models.
In this study, we evaluated the infection potential of PERVs in keratocytes from the SNU miniature pigs using in vitro infectivity tests and investigated long-term evidence of transmission of PERVs using a clinically relevant pig-to-NHP corneal transplantation model. 
| METHODS

| In vitro infection model
To culture keratocytes from the SNU miniature pigs, the epithelium of the cornea was removed using a surgical blade, and the Descemet's membrane was peeled off. The remaining stroma was treated with incubator.
The PERV infectivity test of porcine keratocytes was performed using a coculture method as described elsewhere. 7 Briefly, 1×10 6 keratocytes/mL were plated onto 9×10 5 /mL monolayer-cultured HEK-293 cells. After coculture for 24 hours, the culture media was removed and replaced with fresh medium. Then, the infected cells were subcultured every 3 days and grown in the culture medium.
| In vivo pig-to-non-human primate corneal transplantation model
Porcine corneas were obtained from designated pathogen-free SNU miniature pigs, which were kindly donated by Yoon Berm Kim and PKP procedures were performed as described previously, 2,3,9 and the DALK procedure was performed using the big-bubble technique.
In group 2, subsequent PKPs were performed using 8.5-mm-sized rhesus allocorneal grafts after previously transplanted decellularized porcine grafts were completely removed. In group 4, one recipient (R062) underwent a subsequent PKP using an 8.5-mm-sized porcine corneal graft with the same immunosuppressive regimen after total rejection of the first xenocorneal graft.
After transplantation, all recipients received levofloxacin 0.5% Primary PCR was carried out as described previously, 11 using
AccuPower PCR premix (Bioneer, Seoul, Korea) containing 10 pmol of primary forward and reverse primers for PERV pol or pig cytochrome oxidase II (COII) and 10 pg of prepared DNA in a total volume of 20 μL.
Amplification was performed with 30 cycles at 94°C for 30 seconds, 55°C for 30 seconds, and 72°C for 30 seconds in pol amplification, and with 30 cycles at 94°C for 1 minute, 64°C for 1 minute, and 72°C
for 1 minute in COII amplification. Nested PCR was performed with the same conditions using 1/20 of the amplified products instead of the prepared DNA. The products were then separated on 2% agarose gels (SeaKem, Rockland, ME, USA). In this nested PCR, PERV pol, and COII could be detected up to 0.1 pg and 1×10 −3 pg per reaction, respectively.
| RESULTS
| PERV expression in the SNU miniature pig cornea
Both PCR and RT-PCR reactions using the SNU miniature pig corneas showed positive signals for both PERV pol and COII, which implies the presence of PERV-expressing cells in the porcine corneal tissues (Figure 1 ).
| PERV detection in the in vitro infectivity test
Two independent experiments detected both PERV pol and COII in all early coculture samples, which suggested the presence of porcine keratocytes. However, both PERV pol and COII were not detected in any sample after 41 and 92 days of coculture, respectively (Table S1 ).
| PERV detection in the recipients after xenocorneal transplantation
Three different types of porcine corneas (freshly preserved partial thickness, decellularized partial thickness and freshly preserved fullthickness) were transplanted into NHP recipients. These porcine corneal grafts survived from 21 to 986 days in the recipients' corneal beds. Total exposure time to PERVs, calculated from when porcine grafts were transplanted until when the grafts were substituted for allografts (group 2) or when the recipients were sacrificed (other groups), ranged from 28 to 1176 days. Final blood and tissue samples were obtained from 28 to 1176 days post-transplantation (Table 1) .
After xenocorneal transplantation, 257 PBMC samples from 22 rhesus recipients were serially collected and investigated for the presence of PERV DNA. All the PBMC samples, except one, were negative for PERV pol as well as COII. One collected from the recipient R034 at 4 weeks post-transplantation was positive for both PERV pol and COII, which implied the presence of porcine cells in the sample. However, all blood samples thereafter until euthanasia (546 days after the first exposure to a porcine graft) were negative for both PERV pol and COII.
Therefore, productive viral replication did not seem to be possible in this recipient (Table 1, Table S2 ). Regarding PERV RNA expression in the recipients' plasma, 34 samples from 12 rhesus recipients showed neither PERV pol nor COII (Table 1, Table S3 ).
In total, 282 tissue samples were obtained at the end of each experiment from thirteen organs in 22 rhesus recipients, which were investigated for the existence of PERV DNA. Neither PERV pol nor COII was evident in any tissue sample ( Table 1, Table S4 ).
| DISCUSSION
In this study, HEK-293 cells cocultured with keratocytes from the SNU miniature pigs showed no detectable PERV DNA after 41 or 92 days coculture, respectively. Employing clinically relevant xenocorneal transplantation models using various types of porcine corneas, NHPs were exposed to PERV-containing xenoantigens for up to 1176 days and demonstrated no detectable PERV DNA and RNA in any long-term (up to postoperative day 1176) follow-up samples, including PBMCs, plasmas and tissues from thirteen different organs.
It has been well documented that PERV expression is different
depending on the pig strain, the individual pig of a given strain, and different organs, 12, 13 although to date, there has been no report on PERV expression in the porcine corneal tissue. In this study, the authors confirmed the existence of PERV DNA and RNA in the porcine corneal tissue, which would suggest the cornea is not exempt from the concerns of xenozoonosis. In addition, it is advised that the source pig herd should be screened for PERV expression in the porcine cells and/or for in vitro transmission of PERV to human target cells.
14-16
Especially, pig strains carrying PERV-C, with the potential to generate PERV-A/C recombinant viruses, are advised to be avoided as source pigs. 17 The SNU miniature pigs were known to carry PERV types A, B, and C in the genome 18 ; however, previous in vitro infectivity tests There is no evidence for PERV transmission to NHP recipients of various transplanted porcine tissues including aortic endothelial cells, acellular vessels, skin, heart, kidney, thymic lobe, and encapsulated islets. [20] [21] [22] [23] [24] [25] [26] [27] [28] However, it is difficult to apply these results directly to the human clinical setting because the actual exposure durations of PERVcontaining porcine products were relatively short, ranging from a few days to a few months in most cases, and long-term follow-up samples could not be tested due to short-term survival of each porcine graft.
This study also found no PERV transmission to NHP recipients after various types of xenocorneal transplantations. These results are noteworthy, as the recipients were continuously exposed to xenoantigens for an extended period of time (>6 months in 17 of 22 (77.3%) recipients, and >1 year in six recipients); thus, long-term follow-up samples were collected up to postoperative day 1176. Moreover, this study expands upon the previous studies mentioned above, as PERV DNA was investigated not only in blood samples but also in thirteen different organs.
An extensive literature review did not find any evidence for longterm PERV transmission from porcine products into human subjects.
Although exposure time to porcine materials was very short, extracorporeal spleen/liver/kidney perfusion [29] [30] [31] and ex vivo treatment using a bioartificial liver support system [32] [33] [34] [35] did not show PERV transmission for up to 8.7 years. 35 No PERV infection was reported for up to 8 years, 36 even after in vivo xenotransplantation using porcine neural tissues, 37 islet cells, 30, 36, 38 or encapsulated islets. [39] [40] [41] A recent study in burn patients treated with live porcine skin grafts showed a negative result for up to 408 months, the longest term analyzed to date. PERV, porcine endogenous retrovirus; COII, pig mitochondrial cytochrome oxidase II; PBMCs, peripheral blood mononuclear cells; LKP, lamellar keratoplasty; PKP, penetrating keratoplasty; DALK, deep anterior lamellar keratoplasty; IVIG, intravenous immunoglobulin; ND, not done.
a Calculated from when porcine grafts were transplanted until the grafts were substituted to allografts (group 2) or the recipients were sacrificed (other groups).
b Calculated from when porcine grafts were transplanted until the recipients were sacrificed. c Brain, heart, kidney, large bowel, liver, lung, mesenteric lymph node, muscle, skin, small bowel, spleen, stomach, urinary bladder.
d
Blood sample at 4 weeks post-transplantation showed positive for both PERV pol and COII. However, all blood samples afterward were negative for both PERV pol and COII.
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transplantation. In particular, NHP recipients were exposed to PERVcontaining functional grafts for up to 1176 days, and the presence of PERV DNA and RNA was determined in long-term follow-up samples (up to postoperative day 1176), not only in blood samples but also in tissues from thirteen different organs. Furthermore, our results were drawn from a clinically applicable pig-to-NHP corneal transplantation model, which showed long-term survival of xenocorneal grafts under a tolerable immunosuppressive regimen.
In summary, no detectable PERV transmission is evident through long-term follow-up of pig-to-NHP corneal transplantations, despite the existence of PERV-expressing cells in porcine corneas.
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